Avoro Capital Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200M | Sell |
|
|||||
|
2025
Q1 | $225M | Buy |
|
|||||
|
2024
Q4 | $218M | Buy |
|
|||||
|
2024
Q3 | $316M | Buy |
|
|||||
|
2024
Q2 | $266M | Buy |
|
|||||
|
2024
Q1 | $149M | Buy |
|
|||||
|
2023
Q4 | $22.7M | Hold |
|
|||||
|
2023
Q3 | $16M | Hold |
|
|||||
|
2023
Q2 | $27.8M | Hold |
|
|||||
|
2023
Q1 | $38.5M | Buy |
|
|||||
|
2022
Q4 | $45.5M | Buy |
|
|||||
|
2022
Q3 | $23.7M | Buy |
|
|||||
|
2022
Q2 | $18.9M | Hold |
|
|||||
|
2022
Q1 | $24M | Buy |
|
|||||
|
2021
Q4 | $29.2M | Buy |
|
|||||
|
2021
Q3 | $28.3M | Buy |
|
|||||
|
2021
Q2 | $13.5M | Hold |
|
|||||
|
2021
Q1 | $11.9M | Hold |
|
|||||
|
2020
Q4 | $13.9M | Hold |
|
|||||
|
2020
Q3 | $15.3M | Sell |
|
|||||
|
2020
Q2 | $16.5M | Buy |
|